Sarepta therapeutics announces second quarter 2020 financial results and recent corporate developments

Sarepta therapeutics announces second quarter 2020 financial results and recent corporate developments.q2 non-gaap loss per share $1.51.q2 earnings per share estimate $-1.72 -- refinitiv ibes data.qtrly net product sales of $111.3 million, an 18% increase over same quarter of prior year.
SRPT Ratings Summary
SRPT Quant Ranking